Programmable therapeutic nanobots turned reality.
Oncolytic Virotherapy is the future of cancer immunotherapy.
Discovering viral cancer immunotherapies through engineered virus evolution
Creating the next-generation of viral immunotherapies through genetically reprogrammed evolution.
Oncolytic viruses engineered for precision immunomodulation.
Artificially selected for their unprecedented
GEEN uses proprietary high-throughput directed evolution technology to generate novel viral cancer immunotherapies out of conventional oncolytic virus backbones.
Intellivir Clinics™ Personalized Oncolytic Viruses
Providing the highest degree of personalization. Viral clones tailored to each patient. Personalized on in vitro or in vivo models from patients' immune cells & tumor samples.
Intellivir Discovery™ Developing the next generation of oncolytic viruses
Library generation, high-throughput screening & in vitro/in vivo artificial selection of oncolytic virus clones for precision immunomodulation.
We open Intellivir Discovery Platform for co-development projects with other companies & academia
interested in developing precisely immunomodulating higher efficacy clones of their oncolytic viruses.
See Intellivir Pipeline
See Active Studies